Ezra Holdings Limited (NASDAQ:EZRA) Sees Large Decline in Short Interest

Ezra Holdings Limited (NASDAQ:EZRA) was the recipient of a significant decline in short interest in September. As of September 30th, there was short interest totaling 8,626 shares, a decline of 52.4% from the September 15th total of 18,115 shares. Based on an average daily trading volume, of 30,758 shares, the days-to-cover ratio is presently 0.3 days.

Insider Activity at Ezra

In related news, VP Yaakov Beyman sold 9,120 shares of the company’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $3.83, for a total transaction of $34,929.60. Following the transaction, the vice president owned 2,967 shares of the company’s stock, valued at $11,363.61. This represents a 75.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Ben Fruchtzweig sold 7,448 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $4.08, for a total value of $30,387.84. Following the completion of the transaction, the director owned 5 shares of the company’s stock, valued at $20.40. The trade was a 99.93% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 34,727 shares of company stock worth $124,161 over the last three months.

Ezra Stock Performance

Shares of EZRA traded down $0.09 on Friday, reaching $2.39. The stock had a trading volume of 34,003 shares, compared to its average volume of 791,072. The firm has a 50-day moving average of $2.57 and a 200 day moving average of $3.86. Ezra has a twelve month low of $1.75 and a twelve month high of $53.20.

Ezra (NASDAQ:EZRA) last issued its quarterly earnings data on Thursday, July 30th. The company reported ($3.26) earnings per share (EPS) for the quarter. The company had revenue of $2.11 million during the quarter.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on EZRA. Wall Street Zen cut shares of Ezra from a “hold” rating to a “sell” rating in a research note on Saturday, September 5th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Ezra in a research note on Friday, October 2nd. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

About Ezra

Ezra (NASDAQ: EZRA) is a health care technology company focused on improving cancer screening and early detection. The company combines magnetic resonance imaging (MRI) with artificial intelligence to help identify potential cancer and other abnormalities, with the goal of making screening more accessible, efficient and comprehensive.

Its services include Ezra Screen, an MRI-based screening program designed to examine multiple areas of the body in a single session, as well as related imaging and cancer-screening services.